The patent refers to how ATL1102 inter reacts with some proteins, and its mode of operation. it is this interaction with some proteins that gives benefit. And these proteins are common in many inflammation disease. So individual disease does need to be mentioned. Just how the drug works and against what. Any disease with this biomarker becomes a target. The patent I have bolded is the one. Spelling went amiss during the copy and paste.
I remember this announcement very well. It was a huge event as this not only gives confidence in how the drug works against DMD, but also is proof that will help the FDA understand that our drug does work. This is something a recent DMD drug couldn't do, but it still got approved.
This also means data gained in one indication adds to data for other indications with the same biomarkers.
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-2987
-
- There are more pages in this discussion • 541 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.003(3.57%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.4¢ | 8.7¢ | 8.4¢ | $72.99K | 855.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 398595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 0.084 |
3 | 212500 | 0.083 |
2 | 106250 | 0.080 |
2 | 125578 | 0.079 |
1 | 12462 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 398595 | 1 |
0.088 | 400000 | 1 |
0.089 | 135000 | 2 |
0.090 | 794374 | 5 |
0.092 | 50000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online